Printer-friendly: Click to view
  • Summary date: Feb 12 2019 - View Summary

    Amends GS 90-21.82, which requires voluntary, informed consent for an abortion to be performed upon a woman. Adds to the conditions which must be met to constitute voluntary, informed consent, a requirement for any physician who prescribes, dispenses, or otherwise provides any drug or chemical for abortion-inducing purposes to furnish the patient with written information made available by the Department of Health and Human Services (DHHS), pursuant to GS 90-21.83 (amended below), immediately after administering the first drug or chemical. Further requires the woman to certify, in writing, that she has been furnished with the specified information and informed of her opportunity to review the information. Makes technical and clarifying changes.

    Amends GS 90-21.83, directing DHHS to publish and make available online materials designed to inform a woman about the possibility of reversing a drug-induced abortion. Provides statement language and font requirements. Mandates DHHS to cause this information to also be made available on the homepage of the state website for the Woman's Right to Know Act. Makes conforming, technical, and clarifying changes. 

    Directs DHHS to, within 90 days of the effective date, (1) publish the information described in GS 90-21.83(a)(3), as amended above, to the homepage of the state website for the Woman's Right to Know Act and (2) make the same information available in printed materials to any physician, upon request, at no cost.

    Includes a severability clause. Effective October 1, 2019.